Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

by COMPASS Investigators, Alings, M, Anand, SS, Avezum, A, Bhatt, DL, Bosch, J, Branch, KRH, Bruns, NC, Commerford, PJ, Connolly, SJ, Dagenais, GR, Dans, A, Diaz, R, Dyal, L, Eikelboom, JW, Ertl, G, Felix, C, Fox, KAA, Guzik, T, Hart, RG, Hori, M, Kakkar, A, Keltai, M, Kim, JH, Lanas, F, Leong, D, Lewis, BS, Liang, Y, Lonn, EM, Lopez-Jaramillo, P, Maggioni, AP, Metsarinne, K, Moayyedi, P, Muehlhofer, E, ODonnell, M, Parkhomenko, AN, Piegas, LS, Pogosova, N, Probstfield, J, Ryden, L, Shestakovska, O, Steg, PG, Stork, S, Tonkin, AM, Torp-Pedersen, C, Verhamme, PB, Vinereanu, D, Widimsky, P, Yusoff, K, Yusuf, S, Zhu, J
Published 2019

Wheelchair Skills Training: A scoping review

by Daud, AZC, Rahim, MZA, Yang, NAA
Published 2021